Pulmatrix (NASDAQ:PULM) reported a Q4 loss of $(0.57) per share, beating the analyst consensus estimate of $(1.04) by 45.19%. Sales for the quarter were $2.20 million, surpassing the estimate of $1.77 million by 24.41%. The company's losses increased by 50% compared to the same period last year, while sales saw a 28.92% increase.
Pulmatrix (NASDAQ:PULM) reported quarterly losses of $(0.57) per share which beat the analyst consensus estimate of $(1.04) by 45.19 percent. This is a 50 percent increase over losses of $(1.14) per share from the same period last year. The company reported quarterly sales of $2.20 million which beat the analyst consensus estimate of $1.77 million by 24.41 percent. This is a 28.92 percent increase over sales of $1.71 million the same period last year.
